TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio L AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
191
|
188 | |
| Financial expenses |
1
|
1 | |
| Earnings before taxes |
16
|
4 | |
| EBITDA |
27
|
13 | |
| Total assets |
67
|
55 | |
| Current assets |
26
|
35 | |
| Current liabilities |
43
|
39 | |
| Equity capital |
22
|
15 | |
| - share capital |
5
|
4 | |
| Employees (average) |
2
|
2
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
32.8%
|
27.3% | |
| Turnover per employee |
96
|
188 | |
| Profit as a percentage of turnover |
8.4%
|
2.1% | |
| Return on assets (ROA) |
25.4%
|
9.1% | |
| Current ratio |
60.5%
|
89.7% | |
| Return on equity (ROE) |
72.7%
|
26.7% | |
| Change turnover |
3
|
0 | |
| Change turnover % |
25%
|
2%
|
0% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
100%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.